BCWORLD PHARM. Co. Ltd (200780) — Financial Flexibility Index
BCWORLD PHARM. Co. Ltd (200780) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of ₩3.06 Billion (operating CF ₩1.43 Billion minus capex ₩1.63 Billion) represents 0% of total liabilities (₩101.30 Billion). Check how strategically is BCWORLD PHARM. Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BCWORLD PHARM. Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for BCWORLD PHARM. Co. Ltd across 10 annual periods. See 200780 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for BCWORLD PHARM. Co. Ltd. For the full company profile including market capitalisation, see market cap of BCWORLD PHARM. Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | ₩6.45 Billion | ₩4.04 Billion | ₩99.65 Billion | ▼ -51.4% |
| 2023 | 0.13x | ₩13.65 Billion | ₩10.94 Billion | ₩102.47 Billion | ▲ +5.2% |
| 2022 | 0.13x | ₩13.10 Billion | ₩6.88 Billion | ₩103.50 Billion | ▼ -26.3% |
| 2021 | 0.17x | ₩16.82 Billion | ₩-619.83 Million | ₩97.90 Billion | ▲ +587.1% |
| 2020 | 0.03x | ₩2.28 Billion | ₩-5.50 Billion | ₩91.27 Billion | ▼ -94.3% |
| 2019 | 0.44x | ₩33.43 Billion | ₩12.11 Billion | ₩75.53 Billion | ▼ -10.1% |
| 2018 | 0.49x | ₩35.26 Billion | ₩5.34 Billion | ₩71.65 Billion | ▼ -25.4% |
| 2017 | 0.66x | ₩24.48 Billion | ₩7.90 Billion | ₩37.11 Billion | ▲ +16.1% |
| 2016 | 0.57x | ₩12.81 Billion | ₩243.66 Million | ₩22.54 Billion | ▼ -80.1% |
| 2015 | 2.85x | ₩34.04 Billion | ₩8.78 Billion | ₩11.96 Billion | — |